Non-apoptotic regulated cell death mediates reprogramming of the tumour immune microenvironment by macrophages

被引:4
作者
Sun, Chengpeng [1 ,2 ]
Zhan, Jianhao [2 ]
Li, Yao [3 ]
Zhou, Chulin [4 ]
Huang, Shuo [4 ]
Zhu, Xingen [1 ,5 ,6 ,7 ]
Huang, Kai [1 ,5 ,6 ,7 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Jiangxi Med Coll, Dept Neurosurg, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Huankui Acad, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R China
[3] Nanchang Univ, Clin Med Coll 1, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R China
[4] Nanchang Univ, Clin Med Coll 2, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R China
[5] Nanchang Univ, Inst Neurosci, Jiangxi Med Coll, Nanchang, Jiangxi, Peoples R China
[6] Jiangxi Key Lab Neurol Tumors & Cerebrovasc Dis, Nanchang, Peoples R China
[7] JXHC Key Lab Neurol Med, Nanchang, Jiangxi, Peoples R China
关键词
autophagy; ferroptosis; immunotherapy; necroptosis; non-apoptotic regulated cell death; pyroptosis; tumour immune microenvironment; tumour-associated macrophages; NEUTROPHIL EXTRACELLULAR TRAPS; NECROPTOSIS ADAPTER RIPK3; MOLECULAR-MECHANISMS; EFFECTOR FUNCTION; INDUCED CYTOKINE; CANCER-CELLS; AUTOPHAGY; ACTIVATION; FERROPTOSIS; RECEPTOR;
D O I
10.1111/jcmm.18348
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tumour immune microenvironment (TIME) plays an indispensable role in tumour progression, and tumour-associated macrophages (TAMs) are the most abundant immune cells in TIME. Non-apoptotic regulated cell death (RCD) can avoid the influence of tumour apoptosis resistance on anti-tumour immune response. Specifically, autophagy, ferroptosis, pyroptosis and necroptosis mediate the crosstalk between TAMs and tumour cells in TIME, thus reprogram TIME and affect the progress of tumour. In addition, although some achievements have been made in immune checkpoint inhibitors (ICIs), there is still defect that ICIs are only effective for some people because non-apoptotic RCD can bypass the apoptosis resistance of tumour. As a result, ICIs combined with targeting non-apoptotic RCD may be a promising solution. In this paper, the basic molecular mechanism of non-apoptotic RCD, the way in which non-apoptotic RCD mediates crosstalk between TAMs and tumour cells to reprogram TIME, and the latest research progress in targeting non-apoptotic RCD and ICIs are reviewed.
引用
收藏
页数:21
相关论文
共 198 条
[1]   Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity [J].
Aaes, Tania Love ;
Kaczmarek, Agnieszka ;
Delvaeye, Tinneke ;
De Craene, Bram ;
De Koker, Stefaan ;
Heyndrickx, Liesbeth ;
Delrue, Iris ;
Taminau, Joachim ;
Wiernicki, Bartosz ;
De Groote, Philippe ;
Garg, Abhishek D. ;
Leybaert, Luc ;
Grooten, Johan ;
Bertrand, Mathieu J. M. ;
Agostinis, Patrizia ;
Berx, Geert ;
Declercq, Wim ;
Vandenabeele, Peter ;
Krysko, Dmitri V. .
CELL REPORTS, 2016, 15 (02) :274-287
[2]   Chronic Hepatitis C Virus Infection Impairs M1 Macrophage Differentiation and Contributes to CD8+ T-Cell Dysfunction [J].
Ahmed, Faria ;
Ibrahim, Andrea ;
Cooper, Curtis L. ;
Kumar, Ashok ;
Crawley, Angela M. .
CELLS, 2019, 8 (04)
[3]   Recent insights into the function of autophagy in cancer [J].
Amaravadi, Ravi ;
Kimmelman, Alec C. ;
White, Eileen .
GENES & DEVELOPMENT, 2016, 30 (17) :1913-1930
[4]   Necroptosis in pancreatic cancer promotes cancer cell migration and invasion by release of CXCL5 [J].
Ando, Yohei ;
Ohuchida, Kenoki ;
Otsubo, Yoshiki ;
Kibe, Shin ;
Takesue, Shin ;
Abe, Toshiya ;
Iwamoto, Chika ;
Shindo, Koji ;
Moriyama, Taiki ;
Nakata, Kohei ;
Miyasaka, Yoshihiro ;
Ohtsuka, Takao ;
Oda, Yoshinao ;
Nakamura, Masafumi .
PLOS ONE, 2020, 15 (01)
[5]  
[Anonymous], 2022, Science, V376
[6]   LC3-Associated Phagocytosis (LAP): A Potentially Influential Mediator of Efferocytosis-Related Tumor Progression and Aggressiveness [J].
Asare, Patrick F. ;
Roscioli, Eugene ;
Hurtado, Plinio R. ;
Tran, Hai B. ;
Mah, Chui Yan ;
Hodge, Sandra .
FRONTIERS IN ONCOLOGY, 2020, 10
[7]   Lipid storage and lipophagy regulates ferroptosis [J].
Bai, Yuansong ;
Meng, Lingjun ;
Han, Leng ;
Jia, Yuanyuan ;
Zhao, Yanan ;
Gao, Huan ;
Kang, Rui ;
Wang, Xiaofeng ;
Tang, Daolin ;
Dai, Enyong .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2019, 508 (04) :997-1003
[8]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[9]   Resistance to immunotherapy in human malignancies: Mechanisms, research progresses, challenges, and opportunities [J].
Bashash, Davood ;
Zandi, Zahra ;
Kashani, Bahareh ;
Pourbagheri-Sigaroodi, Atieh ;
Salari, Sina ;
Ghaffari, Seyed H. .
JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (01) :346-372
[10]   Challenges and Opportunities for Pancreatic Cancer Immunotherapy [J].
Bear, Adham S. ;
Vonderheide, Robert H. ;
O'Hara, Mark H. .
CANCER CELL, 2020, 38 (06) :788-802